摘要
磁共振成像(MRI)已成为肿瘤早期诊断的一项有前途的技术,尤其是造影剂的应用可以进一步提高检测限。比较机智“阴性”造影剂(T2)中的暗信号(T2)、具有明亮信号的“正”造影剂(T1)中的暗信号更适合于高分辨率成像。然而,临床使用的钆配合物ES有较短的循环时间和肾系统纤维化的风险。因此,为了克服t2智能体和传统t1智能体的不足,开发纳米级的智能体是非常有意义的。DT1加权MRI造影剂具有更安全、更精确的成像性能。本文系统地综述了顺磁和超顺磁性无机纳米的研究进展。作为t1加权mri造影剂的粒子,包括氧化钆纳米颗粒、钆化上转换纳米颗粒、氧化锰纳米粒子和超细氧化铁纳米颗粒。女同性恋。此外,我们还描述了它们在多模态成像和可视化热学中的应用。
关键词: 顺磁性和超顺磁性无机纳米颗粒,钆基纳米颗粒,锰氧化物,超小氧化铁,T1加权磁共振成像,可视化理论。
Current Medicinal Chemistry
Title:Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging
Volume: 25 Issue: 25
关键词: 顺磁性和超顺磁性无机纳米颗粒,钆基纳米颗粒,锰氧化物,超小氧化铁,T1加权磁共振成像,可视化理论。
摘要: Magnetic resonance imaging (MRI) has become a promising technique in the early diagnosis of cancers, especially the application of contrast agents can further enhance the detection limit. Compared with the dark signal in “negative” contrast agents (T2), “positive” contrast agents (T1) with bright signal are more desirable for high-resolution imaging. However, the clinically used gadolinium complexes have short circulation time and the risk of nephrogenic system fibrosis. Therefore, to overcome the disadvantage of T2 agents and traditional T1 agents, it is very interesting to develop nano-scaled T1-weighted MRI contrast agents with safer and more precise imaging performance. The present review systematically summarized the recent progress of paramagnetic and superparamagnetic inorganic nanoparticles as T1-weighted MRI contrast agents, including gadolinium oxide nanoparticles, gadoliniumbased upconversion nanoparticles, manganese oxide nanoparticles, and ultra-small iron oxide nanoparticles. Moreover, we also described their applications in multi-modal imaging and visualized theranostics.
Export Options
About this article
Cite this article as:
Paramagnetic and Superparamagnetic Inorganic Nanoparticles for T1-Weighted Magnetic Resonance Imaging, Current Medicinal Chemistry 2018; 25 (25) . https://dx.doi.org/10.2174/0929867324666170314124616
DOI https://dx.doi.org/10.2174/0929867324666170314124616 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements